Levexx 500 Tablet contains Levetiracetam 500 mg, an antiepileptic medication primarily indicated for the treatment of partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, thereby reducing neuronal excitability and seizure propagation. Levexx 500 is prescribed as monotherapy or adjunctive therapy in adults and pediatric patients aged one month and older. The tablet is typically administered orally, with dosage individualized based on patient age, renal function, and clinical response. Common adverse effects include somnolence, dizziness, fatigue, headache, and irritability, which are generally mild to moderate and transient. Caution is advised in patients with renal impairment, and dose adjustments may be necessary. Levexx 500 should be used under strict medical supervision, with gradual dose titration to minimize side effects and optimize seizure control. Abrupt discontinuation is discouraged due to the risk of increased seizure frequency. This medication does not significantly interact with other antiepileptic drugs, enhancing its suitability in polytherapy regimens. Overall, Levexx 500 Tablet is a well-tolerated and effective option for managing various seizure disorders.